These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38847635)

  • 1. Epidemiology of Coronavirus Disease 2019 during the Second and Third Wave in Chennai, India: An Analysis of the Coronavirus Disease 2019 Surveillance System, February 2021-February 2022.
    Parasuraman G; Kaviprawin M; Sakthivel M; Jagadeesan M; Varghese AJ; Sriramulu HM; Ramamurthy S; Murali S; Rubeshkumar P; Murugesan L; Ganapathi R; Srinivasan M; Kaur P
    Indian J Public Health; 2024 Jan; 68(1):60-65. PubMed ID: 38847635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of COVID-19 and effect of public health interventions, Chennai, India, March-October 2020: an analysis of COVID-19 surveillance system.
    M J; Ganeshkumar P; Kaur P; Masanam Sriramulu H; Sakthivel M; Rubeshkumar P; Raju M; Murugesan L; Ganapathi R; Srinivasan M; Sukumar A; Ilangovan K; Reddy M; Shanmugam D; Govindasamy P; Murhekar M
    BMJ Open; 2022 Mar; 12(3):e052067. PubMed ID: 35288381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-cause mortality during the COVID-19 pandemic in Chennai, India: an observational study.
    Lewnard JA; Mahmud A; Narayan T; Wahl B; Selvavinayagam TS; Mohan B C; Laxminarayan R
    Lancet Infect Dis; 2022 Apr; 22(4):463-472. PubMed ID: 34953536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
    Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
    Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020.
    ; ; ;
    Indian J Med Res; 2020 May; 151(5):424-437. PubMed ID: 32611914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and public health response in early phase of COVID-19 pandemic, Veneto Region, Italy, 21 February to 2 April 2020.
    Russo F; Pitter G; Da Re F; Tonon M; Avossa F; Bellio S; Fedeli U; Gubian L; Monetti D; Saia M; Zanella F; Zorzi M; Narne E; Mantoan D
    Euro Surveill; 2020 Nov; 25(47):. PubMed ID: 33243356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
    Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for face mask compliance, Chennai, Tamil Nadu, India, October-December, 2020.
    M J; Rubeshkumar P; Raju M; Sakthivel M; Murali S; Nagarajan R; Sendhilkumar M; Sambath I; Ilangovan K; Harikrishnan D; Venkatasamy V; Ganeshkumar P; Reddy M; Kaur P
    PLoS One; 2021; 16(9):e0257739. PubMed ID: 34559845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes among Asymptomatic or Mildly Symptomatic COVID-19 Patients in an Isolation Facility in Chennai, India.
    Krishnasamy N; Natarajan M; Ramachandran A; Vivian Thangaraj JW; Etherajan T; Rengarajan J; Shanmugasundaram M; Kandasamy A; Ramamoorthy R; Velusamy A; Obla Lakshmanamoorthy NB; Kanagaraman P; Rahamathula MI; Devadas G; Sathyanathan BP; Rajaji P; Rajendran K; Panneerselvam P; Rajaram M; Panjacharam M
    Am J Trop Med Hyg; 2021 Jan; 104(1):85-90. PubMed ID: 33205749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19, Australia: Epidemiology Report 18 (Fortnightly reporting period ending 7 June 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32552623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age- & sex-specific infection fatality ratios for COVID-19 estimated from two serially conducted community-based serosurveys, Chennai, India, 2020.
    Vivian Thangaraj JW; Kumar MS; Velusamy S; Girish Kumar CP; Selvaraju S; Sabarinathan R; Jagadeesan M; Hemalatha MS; Bhatnagar T; Murhekar MV
    Indian J Med Res; 2021 May; 153(5&6):546-549. PubMed ID: 34528527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.
    Pan A; Liu L; Wang C; Guo H; Hao X; Wang Q; Huang J; He N; Yu H; Lin X; Wei S; Wu T
    JAMA; 2020 May; 323(19):1915-1923. PubMed ID: 32275295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the Delta and Omicron waves in the United States: a retrospective cohort study.
    Li JX; Liao PL; Wei JC; Hsu SB; Yeh CJ
    Front Public Health; 2023; 11():1143650. PubMed ID: 37799149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in cancer incidence in Chennai city (1982-2006) and statewide predictions of future burden in Tamil Nadu (2007-16).
    Swaminathan R; Shanta V; Ferlay J; Balasubramanian S; Bray F; Sankaranarayanan R
    Natl Med J India; 2011; 24(2):72-7. PubMed ID: 21668047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February-6 June 2020.
    Elimian KO; Ochu CL; Ilori E; Oladejo J; Igumbor E; Steinhardt L; Wagai J; Arinze C; Ukponu W; Obiekea C; Aderinola O; Crawford E; Olayinka A; Dan-Nwafor C; Okwor T; Disu Y; Yinka-Ogunleye A; Kanu NE; Olawepo OA; Aruna O; Michael CA; Dunkwu L; Ipadeola O; Naidoo D; Umeokonkwo CD; Matthias A; Okunromade O; Badaru S; Jinadu A; Ogunbode O; Egwuenu A; Jafiya A; Dalhat M; Saleh F; Ebhodaghe GB; Ahumibe A; Yashe RU; Atteh R; Nwachukwu WE; Ezeokafor C; Olaleye D; Habib Z; Abdus-Salam I; Pembi E; John D; Okhuarobo UJ; Assad H; Gandi Y; Muhammad B; Nwagwogu C; Nwadiuto I; Sulaiman K; Iwuji I; Okeji A; Thliza S; Fagbemi S; Usman R; Mohammed AA; Adeola-Musa O; Ishaka M; Aketemo U; Kamaldeen K; Obagha CE; Akinyode AO; Nguku P; Mba N; Ihekweazu C
    Epidemiol Infect; 2020 Sep; 148():e208. PubMed ID: 32912370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19, Australia: Epidemiology Report 16 (Reporting week to 23:59 AEST 17 May 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 May; 44():. PubMed ID: 32522141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19, Australia: Epidemiology Report 17 (Fortnightly reporting period ending 24 May 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32517645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, March-August 2020.
    Undurraga EA; Chowell G; Mizumoto K
    Infect Dis Poverty; 2021 Feb; 10(1):11. PubMed ID: 33531085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and Comorbidities: Audit of 2,000 COVID-19 Deaths in India.
    Koya SF; Ebrahim SH; Bhat LD; Vijayan B; Khan S; Jose SD; Pilakkadavath Z; Rajeev P; Azariah JL
    J Epidemiol Glob Health; 2021 Jun; 11(2):230-232. PubMed ID: 33876594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.